CY1108110T1 - Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου - Google Patents

Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου

Info

Publication number
CY1108110T1
CY1108110T1 CY20081100577T CY081100577T CY1108110T1 CY 1108110 T1 CY1108110 T1 CY 1108110T1 CY 20081100577 T CY20081100577 T CY 20081100577T CY 081100577 T CY081100577 T CY 081100577T CY 1108110 T1 CY1108110 T1 CY 1108110T1
Authority
CY
Cyprus
Prior art keywords
corruption
factors
treatment
protection
methods
Prior art date
Application number
CY20081100577T
Other languages
English (en)
Inventor
Dvm Todd R Henderson
Rn Dvm Barbara E Corson
Tarek Hammad
Medhat Soliman
Louis Lippiello
Original Assignee
Nutramax Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories, Inc. filed Critical Nutramax Laboratories, Inc.
Publication of CY1108110T1 publication Critical patent/CY1108110T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Reinforced Plastic Materials (AREA)
  • Inorganic Insulating Materials (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με συνθέσεις για την προστασία, θεραπεία και επιδιόρθωση συνδετικών ιστών σε ανθρώπους και ζώα που περιλαμβάνουν οποιουσδήποτε ή όλους από αναβολικούς, αντι-καταβολικούς, και αντι-οξειδωτικούς παράγοντες, περιλαμβάνοντας αμινοσάκχαρα, S-αδενοσυλομεθειονίνη, αραχαδονικό οξύ, GAGs, πεντοζάνη, κολλαγόνο τύπου II, τετρακυκλίνες ή ενώσεις προσομοιάζουσες τετρακυκλίνη, diacerin, υπεροξειδική δισμουτάση, και L-εργοθειονίνη και με μεθόδους υποβολής σε θεραπεία ανθρώπων και ζώων με χορήγηση αυτών των καινοφανών συνθέσεων σε ανθρώπους και ζώα που τη χρειάζονται.
CY20081100577T 1998-02-13 2008-06-03 Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου CY1108110T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7459498P 1998-02-13 1998-02-13
EP99906947A EP1053000B1 (en) 1998-02-13 1999-02-12 Agents and methods for protection, treatment and repair of connective tissue

Publications (1)

Publication Number Publication Date
CY1108110T1 true CY1108110T1 (el) 2014-02-12

Family

ID=22120420

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100577T CY1108110T1 (el) 1998-02-13 2008-06-03 Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου

Country Status (12)

Country Link
EP (2) EP1917966B1 (el)
JP (1) JP2002502881A (el)
AT (2) ATE455548T1 (el)
AU (1) AU764431B2 (el)
CA (1) CA2320202C (el)
CY (1) CY1108110T1 (el)
DE (2) DE69938036D1 (el)
DK (2) DK1917966T3 (el)
ES (2) ES2338946T3 (el)
HK (1) HK1120211A1 (el)
PT (2) PT1053000E (el)
WO (1) WO1999040926A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
DE10054257A1 (de) * 2000-11-02 2002-05-16 Kief Horst Heilmittel zur Intraarticulären Injektion
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
MX2007011931A (es) * 2007-09-26 2009-03-26 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartritis y enfermedades relacionadas.
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US11000533B2 (en) 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
AU2011363947B2 (en) * 2011-03-25 2017-01-05 Trackside Technologies Pty Ltd Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US20230248808A1 (en) * 2020-01-29 2023-08-10 Lonza Greenwood Llc Joint Health Composition and Use Thereof in Healthy Mammals
WO2024018956A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネイン又はその塩に由来する苦味及びコンドロイチン硫酸又はその塩に由来する臭みを抑制する方法
WO2024018955A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネインに由来する苦味及びグルコサミン類化合物に由来する異味を抑制する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
JPS63203628A (ja) * 1987-02-19 1988-08-23 Taiyo Kagaku Co Ltd 動物の***炎治療剤
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
JPH09143492A (ja) * 1995-11-17 1997-06-03 Katsumasa Koike 酸化脂質の確認方法及び酸化脂質の生成方法
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico

Also Published As

Publication number Publication date
EP1053000A1 (en) 2000-11-22
DE69938036D1 (de) 2008-03-13
EP1917966A1 (en) 2008-05-07
DK1917966T3 (da) 2010-03-15
CA2320202C (en) 2010-09-14
DK1053000T3 (da) 2008-09-01
EP1917966B1 (en) 2010-01-20
CA2320202A1 (en) 1999-08-19
JP2002502881A (ja) 2002-01-29
WO1999040926A1 (en) 1999-08-19
ATE455548T1 (de) 2010-02-15
EP1053000B1 (en) 2008-05-07
DE69941966D1 (de) 2010-03-11
ES2302373T3 (es) 2008-07-01
ATE394108T1 (de) 2008-05-15
ES2338946T3 (es) 2010-05-13
AU2674099A (en) 1999-08-30
HK1120211A1 (en) 2009-03-27
EP1053000A4 (en) 2003-01-29
PT1053000E (pt) 2008-07-11
AU764431B2 (en) 2003-08-21
PT1917966E (pt) 2010-03-17

Similar Documents

Publication Publication Date Title
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
ATE316786T1 (de) Behandlung von mukositis
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
DE782855T1 (de) Antiinflammatorische wirkstoffe zur aüsserlichen anwendung
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
AU2807195A (en) Hair growing agent
DE69019363T2 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
PT693285E (pt) Composicoes farmaceuticas contendo um bifosfonato e um agente anti-resorcao para inibir a perda ossea
ATE186220T1 (de) Wundheilung
NO304983B1 (no) Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
PT796618E (pt) Tratamento e profilaxia da pancreatite
ES2150727T3 (es) Microbicidas.
ATE173930T1 (de) Pharmazeutische zusammensetzungen zur topischen anwendung die ein chelatierungsmittel, ein tocopherol und einen antimikrobiellen wirkstoff enthalten
DE69206913D1 (de) Formulierungen zur Behandlung der vaginalen Trockenheit
AU6010599A (en) Prevention and treatment of parodontitis
DE69426021T2 (de) Xamonelin-Tartrat
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
BR9901387A (pt) Composições para a cura de polìmero.
DE60141994D1 (de) 13-substituierte Methacyclinverbindungen
RU96122690A (ru) Лекарственное средство для наружного лечения псориаза